|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Argos Therapeutics Inc (ARGS) |
|
|
$0.05 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
10,560,000 |
| Market
Cap: |
565.49(K) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.05355 - $0.05355 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Harrelson Lori R. |
Vice President Finance |
• – – |
2017-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
3,694 |
33,699 |
|
- |
|
| Winterbottom Joan |
Chief Human Resources Officer |
• – – |
2017-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
4,464 |
47,248 |
|
- |
|
| Katz Richard D |
VP & Chief Financial Officer |
• – – |
2017-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,958 |
3,958 |
|
- |
|
| Allen Lee F Md Phd |
Chief Medical Officer |
• – – |
2017-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
7,378 |
7,378 |
|
- |
|
| Abbey Jeffrey D |
Chief Executive Officer |
• • – |
2017-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
17,430 |
127,050 |
|
- |
|
| Nicolette Charles A. |
Chief Science Officer |
• – – |
2017-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
16,753 |
92,796 |
|
- |
|
| Carey Robert |
Director |
– • – |
2016-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,351 |
8,206 |
|
- |
|
| Snyderman Ralph |
Director |
– • – |
2016-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
573 |
573 |
|
- |
|
| Krol Igor |
Director |
– • – |
2016-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
1,785 |
3,874 |
|
- |
|
| Mtibelishvily Irackly |
Director |
– • – |
2016-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
395 |
14,895 |
|
- |
|
| Birner Hubert |
Director |
– • – |
2016-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
3,571 |
12,680 |
|
- |
|
| Mtibelishvily Irackly |
Director |
– • – |
2016-12-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
14,500 |
|
- |
|
| Public Joint Stock Co Pharmstandard |
10% Owner |
– – • |
2016-10-07 |
4 |
B |
$4.73 |
$99,330 |
I/I |
21,000 |
13,242,279 |
1.5 |
- |
|
| Public Joint Stock Co Pharmstandard |
10% Owner |
– – • |
2016-10-06 |
4 |
B |
$4.81 |
$12,698 |
I/I |
2,640 |
13,221,279 |
1.5 |
- |
|
| Public Joint Stock Co Pharmstandard |
10% Owner |
– – • |
2016-10-05 |
4 |
B |
$4.85 |
$4,365 |
I/I |
900 |
13,218,639 |
1.42 |
- |
|
| Public Joint Stock Co Pharmstandard |
10% Owner |
– – • |
2016-10-04 |
4 |
B |
$4.69 |
$33,599 |
I/I |
7,164 |
13,217,739 |
1.5 |
- |
|
| Public Joint Stock Co Pharmstandard |
10% Owner |
– – • |
2016-10-03 |
4 |
B |
$4.70 |
$53,148 |
I/I |
11,308 |
13,210,875 |
1.5 |
- |
|
| Public Joint Stock Co Pharmstandard |
10% Owner |
– – • |
2016-09-30 |
4 |
B |
$4.71 |
$142,393 |
I/I |
30,232 |
13,199,567 |
1.5 |
- |
|
| Carey Robert |
Director |
– • – |
2016-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
2,263 |
5,855 |
|
- |
|
| Van Holle Philippe Marie Marcel Joseph |
Director |
– • – |
2016-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
2,263 |
50,955 |
|
- |
|
| Van Deventer Sander |
Director |
– • • |
2016-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
2,263 |
5,057 |
|
- |
|
| Krol Igor |
Director |
– • – |
2016-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,760 |
2,089 |
|
- |
|
| Petrov Andrei Vladimirovich |
Director |
– • – |
2016-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
2,137 |
10,530 |
|
- |
|
| Birner Hubert |
Director |
– • – |
2016-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
3,521 |
9,109 |
|
- |
|
| Public Joint Stock Co Pharmstandard |
10% Owner |
– – • |
2016-09-29 |
4 |
B |
$4.60 |
$69,460 |
I/I |
15,100 |
13,169,335 |
1.5 |
- |
|
128 Records found
|
|
Page 2 of 6 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
